Sandos to start local medicine production in Saudi Arabia in 2027

Sandoz, the Swiss pharmaceutical company, in collaboration with Tabuk Pharmaceuticals, will begin implementing the first phase of a localization project for the manufacturing and packaging of specialized medicines in Saudi Arabia during the first quarter of 2027. The project aims to transfer specialized manufacturing technology, particularly for immunosuppressants and antibiotics, to improve drug security and ensure sustainable local production, with a broader production scale expected to be achieved by the end of 2028. This initiative will help meet the needs of approximately two million Saudi patients and is considered a strategic step to support Saudi Arabia’s Vision 2030 in strengthening the vital pharmaceutical sector.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل